logo
From Karachi to Gaza: Pakistani startup ships prosthetics to child war survivors, World News

From Karachi to Gaza: Pakistani startup ships prosthetics to child war survivors, World News

AsiaOne3 days ago
KARACHI — As soon as eight-year-old Sidra Al Bordeeni returned from the clinic with her prosthetic arm, she jumped on a bicycle in the Jordanian refugee camp where she lives, riding for the first time since a missile strike in Gaza took her arm a year ago.
Sidra was injured while sheltering at Nuseirat School, one of several Gaza schools converted into makeshift refuges from Israeli strikes. Her mother, Sabreen Al Bordeeni, said Gaza's collapsed health services and the family's inability to leave at the time made it impossible to save her hand.
"She's out playing, and all her friends and siblings are fascinated by her arm," Al Bordeeni said on the phone, repeatedly thanking God for this day. "I can't express how grateful I am to see my daughter happy."
The arm was built over 4,000 kilometres away in Karachi by Bioniks, a Pakistani company that uses a smartphone app to take pictures from different angles and create a 3D model for custom prosthetics.
CEO Anas Niaz said the social enterprise startup had fit more than 1,000 custom-designed arms inside Pakistan since 2021 - funded through a mix of patient payments, corporate sponsorship, and donations - but this was its first time providing prosthetics to those impacted in conflict.
Sidra and three-year-old Habebat Allah, who lost both her arms and a leg in Gaza, went through days of remote consultations and virtual fittings. Then Niaz flew from Karachi to Amman to meet the girls and make his company's first overseas delivery.
Sidra's device was funded by Mafaz Clinic in Amman, while donations from Pakistanis paid for Habebat's. Mafaz CEO Entesar Asaker said the clinic partnered with Bioniks for its low costs, remote solutions and ability to troubleshoot virtually.
Niaz said each prosthetic arm costs about US$2,500 (S$3,190), significantly less than the US$10,000 to US$20,000 for alternatives made in the United States.
While Bioniks' arms are less sophisticated than US versions, they provide a high level of functionality for children and their remote process makes them more accessible than options from other countries such as Turkey and South Korea.
"We plan on providing limbs for people in other conflict zones too, like Ukraine, and become a global company," Niaz said.
Globally, most advanced prosthetics are designed for adults and rarely reach children in war zones, who need lighter limbs and replacements every 12-18 months as they grow.
Niaz said they were exploring funding options for Sidra and Habebat's future replacements, adding the cost wouldn't be too high.
"Only a few components would need to be changed," he said, "the rest can be reused to help another child."
Bioniks occasionally incorporates popular fictional characters into its children's prosthetics such as Marvel's Iron Man or Disney's Elsa, a feature Niaz said helps with emotional acceptance and daily use. 'Finally hug my father'
Gaza now has around 4,500 new amputees, on top of 2,000 existing cases from before the war, many of them children, making it one of the highest child-amputation crises per capita in recent history, the UN humanitarian agency OCHA said in March.
An April study by the Palestinian Bureau of Statistics found at least 7,000 children have been injured since Israel's war in Gaza began in October 2023. Local health authorities say more than 50,000 Palestinians have been killed, nearly one-third of them children.
The World Health Organisation has said Gaza's health system is "on its knees" with Israel's border closures drying up critical supplies, meaning the wounded cannot access specialised care, especially amid waves of wounded patients.
"Where it's nearly impossible for healthcare professionals and patients to meet, remote treatment bridges a critical gap, making assessments, fittings, and follow-up possible without travel or specialised centres," said Asadullah Khan, Clinic Manager at ProActive Prosthetic in Leeds, UK, which provides artificial limbs and support for trauma patients.
Bioniks hopes to pioneer such solutions on a large scale but funding remains a roadblock and the company is still trying to form viable partnerships.
Sidra is still adjusting to her new hand, on which she now wears a small bracelet. For much of the past year, when she wanted to make a heart, a simple gesture using both hands, she would ask someone else to complete it. This time, she formed the shape herself, snapped a photo, and sent it to her father, who is still trapped in Gaza.
"What I'm looking forward to most is using both my arms to finally hug my father when I see him," she said.
[[nid:719868]]
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Fuel shortage threatens to turn Gaza's biggest hospital into graveyard, doctors say
Fuel shortage threatens to turn Gaza's biggest hospital into graveyard, doctors say

Straits Times

time4 hours ago

  • Straits Times

Fuel shortage threatens to turn Gaza's biggest hospital into graveyard, doctors say

Sign up now: Get ST's newsletters delivered to your inbox Wounded Palestinians lie on beds at Al-Shifa Hospital, which Gaza's health ministry says is at risk of shutting down due to the Israeli blockade of fuel, in Gaza City July 9, 2025. REUTERS/Mahmoud Issa GAZA - Overwhelmed doctors and patients at Gaza's largest medical centre could soon be plunged into darkness because of dwindling fuel supplies, which doctors say threaten to paralyze Al Shifa hospital as Israel presses on with its military campaign. While Prime Minister Benjamin Netanyahu discussed the fate of Israeli hostages in Gaza with U.S. President Donald Trump in Washington, Al Shifa's patients faced imminent danger, doctors there said. The threat comes from "neither an airstrike nor a missile — but a siege choking the entry of fuel," Dr. Muneer Alboursh, director general of the Gaza Ministry of Health, told Reuters. The shortage is "depriving these vulnerable people of their basic right to medical care, turning the hospital into a silent graveyard," he said. Israeli airstrikes and relentless bombardment have taken a heavy toll on hospitals in Gaza, a tiny strip of land which was under a long, Israeli-led blockade before the war between Israel and Palestinian militant group Hamas erupted 21 months ago. Palestinians and medical workers have accused the Israeli military of attacking hospitals, allegations it rejects. Israel accuses Hamas of operating from medical facilities and running command centres underneath them, something Hamas denies. Top stories Swipe. Select. Stay informed. World Trump's ambassador nominee Sinha sought to defend US' tariff policies at Senate confirmation hearing Singapore Singapore to hire more than 1,000 new educators annually in the next few years, up from 700 Singapore COE prices rise for all categories Singapore Govt watching job situation for fresh graduates closely, exploring further support: Gan Siow Huang Singapore Man who killed cats by throwing them off HDB blocks has jail term doubled to 27 months Singapore $43k fine for undischarged bankrupt doctor who failed to disclose assets worth over $4m Singapore Female primary school teacher charged over alleged sex acts with underage male student Singapore People working in air-conditioned spaces prefer 24 deg C and warmer: Survey Patients in need of medical care, food and water are paying the price. There have been more than 600 attacks on health facilities since the conflict began, the WHO says, without attributing blame. It has described the health sector in Gaza as being "on its knees", with shortages of fuel, medical supplies and frequent arrivals of mass casualties. Just half of Gaza's 36 general hospitals are partially functioning, according to the U.N. agency. Dr. Muhammad Abu Salamiyah, Al Shifa's director, warned of a humanitarian catastrophe due to a fuel crisis posing a direct threat to hospital operations, desalination plants and the water supply system. He accused Israel of "trickle-feeding" fuel to Gaza's hospitals. COGAT, the Israeli military aid coordination agency, did not immediately respond to a request for comment about fuel shortages at Gaza's medical facilities and the risk to patients. OXYGEN RISK Abu Salamiyah said Al Shifa's dialysis department had been shut down to protect the intensive care unit and operating rooms, which can't be without electricity for even a few minutes. There are around 100 premature babies in Gaza City hospitals whose lives are at serious risk, he said. "Oxygen stations will stop working. A hospital without oxygen is no longer a hospital. The lab and blood banks will shut down, and the blood units in the refrigerators will spoil," Abu Salamiyah said, adding that the hospital could become "a graveyard for those inside". Officials at Nasser Medical Complex in Khan Younis are also wondering how they will cope with the fuel crisis. The hospital needs 4,500 litres of fuel per day and it now has only 3,000 litres, enough for 24 hours, said hospital spokesperson Mohammed Sakr. Doctors are performing surgeries without electricity or air conditioning. The sweat from staff is dripping into patients' wounds, he said. "You can have the best hospital staff on the planet, but if they are denied the medicines and the pain killers and now the very means for a hospital to have light ... it becomes an impossibility," said James Elder, a spokesperson for U.N. children's agency UNICEF recently returned from Gaza. The latest bloodshed in the decades-old Israeli-Palestinian conflict was triggered in October 2023, when Hamas-led militants attacked southern Israel, killing around 1,200 people and taking 251 hostages, according to Israeli tallies. Gaza's health ministry says Israel's response has killed over 57,000 Palestinians. It has also caused a hunger crisis, internally displaced almost all Gaza's population and prompted accusations of genocide and war crimes, which Israel denies. REUTERS

Merck nears US$10 billion deal for London-based lung therapy firm Verona, FT reports
Merck nears US$10 billion deal for London-based lung therapy firm Verona, FT reports

Business Times

time11 hours ago

  • Business Times

Merck nears US$10 billion deal for London-based lung therapy firm Verona, FT reports

[LONDON] Merck is nearing a US$10 billion deal to buy lung diseases focussed Verona Pharma, as the US drugmaker is eyeing deals to offset the upcoming patent expiry of its blockbuster cancer drug, the Financial Times reported on Wednesday (Jul 9). The deal values London-based Verona at about US$107 per American depository share, the report said, citing three people familiar with the matter. The reported purchase price represents a premium of about 23 per cent to Verona ADS' last close on the Nasdaq. The deal would be Merck's largest since its US$10.8 billion buyout of Prometheus Biosciences in 2023. News of the upcoming deal sent Verona's US-listed shares soaring about 18 per cent to US$102.8 in premarket trading. Merck and London-based Verona did not immediately respond to Reuters requests for comment. Reuters could not immediately verify the report. Merck has long leaned on its blockbuster cancer drug Keytruda, which generated nearly US$30 billion in sales in 2024, but faces looming patent expiries starting in 2028. BT in your inbox Start and end each day with the latest news stories and analyses delivered straight to your inbox. Sign Up Sign Up In response, the company has ramped up deal-making to broaden its revenue base. Verona, which is also listed in Frankfurt, rose into prominence with the approval of its inhalable, non-steroid treatment Ohtuvayre for patients with chronic obstructive pulmonary disease, a condition affecting nearly 16 million Americans. Its market capitalisation was about US$7.39 billion, according to LSEG data. Over 96 per cent of Verona's first quarter revenue of about US$76 million came from the Ohtuvayre therapy. Last month, FT reported that Merck held talks to buy Swiss biotech MoonLake Immunotherapeutics for more than US$3 billion, while, in March, the US drugmaker also signed an up to US$2 billion licensing agreement for a heart disease drug with Jiangsu Hengrui Pharmaceuticals. Merck's acquisition would fast track the international launch of the drug in countries outside the US, the FT report added. Shares of Merck, valued at over US$204 billion as of Tuesday, are down by more than 18 per cent this year. REUTERS

Singapore-listed hospital operator IHH eyes Indonesia, Vietnam for expansion
Singapore-listed hospital operator IHH eyes Indonesia, Vietnam for expansion

Straits Times

time18 hours ago

  • Straits Times

Singapore-listed hospital operator IHH eyes Indonesia, Vietnam for expansion

Sign up now: Get ST's newsletters delivered to your inbox In Singapore, IHH operates 793 beds across four hospitals – Gleneagles Hospital (above), Mount Elizabeth Hospital, Mount Elizabeth Novena Hospital and Parkway East Hospital. Kuala Lumpur – IHH Healthcare is looking to potential new markets Indonesia and Vietnam as the Malaysian hospital operator continues building scale to offset rising healthcare costs in the region. Indonesia is attractive, thanks to its healthcare reforms and foreign ownership relaxation, while Vietnam has emerged as a booming market, according to chief executive officer Prem Kumar Nair. 'We get a lot of patients from Vietnam into our Singapore operations,' he said in an interview in Kuala Lumpur this week. In Singapore, IHH operates 793 beds across 4 hospitals – Gleneagles Hospital, Mount Elizabeth Hospital, Mount Elizabeth Novena Hospital and Parkway East Hospital, according to its website. It also has 30 Parkway Shenton clinics, as well as other specialty and ancillary services. The company currently operates more than 80 hospitals in 10 countries, including India and China, and has been actively acquiring healthcare facilities in recent years. It bought Island Hospital in Malaysia in 2024. Its Turkish unit Acibadem and Indian affiliate Fortis Healthcare also purchased hospitals in their respective markets in the last two years. The company has US$14 billion (S$17.9 billion) in market capitalisation and is the most valuable listed hospital operator in South-east Asia. The desire to widen expansion in the region comes as IHH looks to make up for rising import costs in the industry. The group is now procuring medical equipment, consumables and generic medications in bulk to cut costs on imported items, Mr Prem Kumar said. Top stories Swipe. Select. Stay informed. Asia Why Japan and South Korea are on different paths in the latest US trade salvo World Trump says steep copper tariffs in store as he broadens his trade war Opinion Is Donald Trump unstoppable? Opinion Hyper-competitive classrooms feed the corporate world's narcissist pipeline Singapore Man charged after he allegedly threw glass bottle at bus window, injuring passenger Business 'It's our grandfather's company, we won't sell', says Wong family as shareholders reject GE delisting bid Singapore Police officer taken to hospital after motorcycle accident on PIE Asia Ex-Malaysian PM Najib's wife Rosmah awarded $30,000 in suit against TikToker IHH is also planning to consolidate its presence in China, according to the CEO. It turned its clinic business into a profitable operation and is seeing rising number of patients at its hospital in Shanghai. Still, China's decision to ease restrictions on foreign investment in healthcare sector will not immediately sway IHH into expanding further in the world's second-largest economy. 'In China, the public sector is a very big competitor to private healthcare,' said Prem Kuma. 'We are the only foreign operator in China who has a combination of clinics, and an ecosystem, so we will build on it.' The company's priorities also include tapping growing opportunities in existing markets, where it's already committed to expanding hospital bed capacity by 33 per cent from 2024 through 2028 – a 4,000 bed target. 'There's no dearth of opportunities in the countries we operate,' he said. Beyond hospitals IHH booked RM6.29 billion ringgit (S$1.9 billion) in first-quarter revenue, an increase of 5.7 per cent from a year ago. Its profit slid 33 per cent to RM514 million, which the company attributed to exceptional accounting adjustments. Singapore, Turkey and Malaysia are currently its main revenue drivers, but the company expects India to become a major contributor in the coming years amid booming demand for private healthcare. With 35 hospitals, India already has IHH's biggest in-country network. Mr Prem Kumar said he was focused on growing out-of-hospital care in IHH's markets – including ambulatory surgical and care centres, along with primary care centres – to help control cost pressures. The group currently operates 60 healthcare facilities that aren't hospitals. 'If we depend on hospitals alone, healthcare costs are going to rise tremendously,' he said. Singapore already has such an ecosystem in place while Hong Kong is headed in that direction, Mr Prem Kumar said. Still, its home market of Malaysia doesn't allow hospital operators to also run other healthcare facilities. IHH plans to make representations to Malaysia's Health Ministry in hopes the rule will be changed. 'We definitely want to move, in Malaysia, into the out-of-hospital sector in a big way as well,' he said. Dual-listed IHH shares in Malaysia have dropped 8.4 per cent so far in 2025, while the Kuala Lumpur stock index has fallen around 7 per cent amid concerns over US tariffs. Its Singapore shares were trading at $2.03 as at 10.57am on July , down 7.3 per cent for the year. BLOOMBERG

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store